U.S., Oct. 17 -- ClinicalTrials.gov registry received information related to the study (NCT07217665) titled 'The Progressive Supranuclear Palsy Clinical Trial Platform - Regimen A: AADvac1' on Sept. 30.
Brief Summary: The Progressive Supranuclear Palsy Clinical Trial Platform (PTP) is a multi-center, multi-regimen clinical trial evaluating the safety and efficacy of investigational products for the treatment of PSP.
Regimen A will evaluate the safety and efficacy of a single study drug, AADvac1, in participants with PSP.
Study Start Date: Dec. 01
Study Type: INTERVENTIONAL
Condition:
PSP - Progressive Supranuclear Palsy
Intervention:
BIOLOGICAL: AADvac1
AADvac1 administration: subcutaneous injection.
BIOLOGICAL: Matching Placebo
...